Common Contracts

AGREEMENT AND PLAN OF MERGER by and among MAST THERAPEUTICS, INC. AP ACQUISITION SUB, INC. and AIRES PHARMACEUTICALS, INC. and FORTIS ADVISORS LLC, in its capacity as Stockholders’ Representative (solely with respect to Section 2.8(b), Section 6.3,...

Agreement and Plan of Merger • May 5th, 2014 • Mast Therapeutics, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  May 5th, 2014
• Company
  Mast Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS AGREEMENT AND PLAN OF MERGER (“Agreement”), dated as of February 7, 2014, is by and among Mast Therapeutics, Inc. a Delaware corporation (“Parent”), AP Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and Aires Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and, solely with respect to Section 2.8(b), Section 6.3, and Article IX hereof, Fortis Advisors LLC, a Delaware limited liability company, in its capacity as representative of the Company Stockholders (the “Stockholders’ Representative”). Capitalized terms used in this Agreement are defined in Section 11.1, or in the applicable Section of this Agreement to which reference is made in Section 11.2.

AGREEMENT AND PLAN OF MERGER by and among SANGAMO BIOSCIENCES, INC. CG ACQUISITION SUB, INC. and CEREGENE, INC. and HAMILTON BIOVENTURE SERVICES, INC., as Stockholders’ Representative Dated as of August 23, 2013

Agreement and Plan of Merger • October 7th, 2013 • Sangamo Biosciences Inc • Biological products, (no disgnostic substances)

• Contract Type
  Agreement and Plan of Merger
• Filed
  October 7th, 2013
• Company
  Sangamo Biosciences Inc
• Industry
  Biological products, (no disgnostic substances)

THIS AGREEMENT AND PLAN OF MERGER (“Agreement”), dated as of August 23, 2013, is by and among Sangamo BioSciences, Inc. a Delaware corporation (“Parent”), CG Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and Ceregene, Inc., a Delaware corporation (the “Company”), and, Hamilton BioVenture Services, Inc. solely in its capacity as representative of the Company Stockholders (the “Stockholders’ Representative”). Capitalized terms used in this Agreement are defined in Section 11.1, or in the applicable Section of this Agreement to which reference is made in Section 11.1.